Elite Pharmaceuticals, Inc. (ELTP)
0.2598
0.00 (0.00%)
USD |
OTCM |
Sep 14, 16:00
Elite Pharmaceuticals Price : 0.2598 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 0.2521 | 0.26 | 0.252 | 0.2598 | 1.237M |
| Sep 11, 2026 | 0.2573 | 0.268 | 0.25 | 0.263 | 397968.0 |
| Sep 10, 2026 | 0.257 | 0.2674 | 0.251 | 0.2511 | 854495.0 |
| Sep 09, 2026 | 0.2599 | 0.2625 | 0.2551 | 0.2571 | 373657.0 |
| Sep 08, 2026 | 0.2579 | 0.2649 | 0.241 | 0.2599 | 685601.0 |
| Sep 04, 2026 | 0.263 | 0.263 | 0.2511 | 0.258 | 2.028M |
| Sep 03, 2026 | 0.2753 | 0.28 | 0.256 | 0.2611 | 1.522M |
| Sep 02, 2026 | 0.2752 | 0.283 | 0.2752 | 0.2762 | 341952.0 |
| Sep 01, 2026 | 0.288 | 0.288 | 0.2752 | 0.2847 | 459526.0 |
| Aug 31, 2026 | 0.2899 | 0.292 | 0.2805 | 0.2875 | 261374.0 |
| Aug 28, 2026 | 0.2995 | 0.2995 | 0.2874 | 0.2888 | 1.930M |
| Aug 27, 2026 | 0.285 | 0.29 | 0.28 | 0.288 | 1.481M |
| Aug 26, 2026 | 0.2869 | 0.2899 | 0.2791 | 0.285 | 954707.0 |
| Aug 25, 2026 | 0.287 | 0.29 | 0.2758 | 0.286 | 998116.0 |
| Aug 24, 2026 | 0.2998 | 0.2999 | 0.2858 | 0.2891 | 700761.0 |
| Aug 21, 2026 | 0.3024 | 0.31 | 0.2844 | 0.295 | 900854.0 |
| Aug 20, 2026 | 0.3034 | 0.3075 | 0.29 | 0.2974 | 1.322M |
| Aug 19, 2026 | 0.305 | 0.305 | 0.2957 | 0.303 | 471998.0 |
| Aug 18, 2026 | 0.3081 | 0.318 | 0.303 | 0.3035 | 463177.0 |
| Aug 17, 2026 | 0.2976 | 0.324 | 0.29 | 0.308 | 1.133M |
| Aug 14, 2026 | 0.30 | 0.32 | 0.2720 | 0.31 | 5.893M |
| Aug 13, 2026 | 0.36 | 0.3749 | 0.355 | 0.3585 | 913100.0 |
| Aug 12, 2026 | 0.361 | 0.372 | 0.3558 | 0.36 | 1.069M |
| Aug 11, 2026 | 0.363 | 0.37 | 0.3601 | 0.361 | 439356.0 |
| Aug 10, 2026 | 0.3556 | 0.3699 | 0.3556 | 0.3601 | 323771.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Nektar Therapeutics | 66.60 |
| Daré Bioscience, Inc. | 0.76 |
| Eton Pharmaceuticals, Inc. | 56.03 |
| ANI Pharmaceuticals, Inc. | 70.73 |
| Corcept Therapeutics, Inc. | 110.57 |
Price Related Metrics
| PE Ratio | 9.878 |
| PS Ratio | 2.067 |
| Price to Book Value | 2.670 |
| Price to Free Cash Flow | 16.63 |
| Earnings Yield | 10.12% |
| Market Cap | 279.84M |
| Operating PE Ratio | 8.145 |
| Normalized PE Ratio | 32.07 |